Reed Jobs has turned Yosemite from a 2023 oncology fund into a 17-person venture firm using AI, grantmaking and company formation to accelerate cancer science from university labs to clinical developm…
Roche's divarasib beat Amgen's Lumakras and Bristol Myers Squibb's Krazati in a head-to-head Phase 3 trial for KRAS G12C non-small cell lung cancer, showing statistically significant improvements in p…
Nvidia's venture arm NVentures disclosed a $10.4 million stake in Generate:Biomedicines, an AI-driven drug discovery company with a Phase 3 asthma trial and FDA Fast Track oncology candidates. The inv…
AI pilot projects often fail to scale due to poor planning, unclear business outcomes, and lack of data governance, according to executives at Fortune Brainstorm Tech. Salesforce's Lashonda Anderson-W…
Companies are launching hundreds of AI projects, but many fail to deliver strategic value, creating inefficiency instead of productivity gains, according to executives at Fortune Brainstorm Tech. Lead…
Amgen CEO Bob Bradway, a self-described "autodidact" who spends weekends learning AI tools and has mandated AI training for his executive team, is navigating the challenge of integrating artificial in…